REFERENCES
- Aiello LP, Brucker AJ, Chang S et al. Evolving guidelines for intravitreous injections. Retina 2004; 24: S3–S19.
- Boon CJF, Crama N, Klevering BJ et al. Reflux after intravitreal injection of bevacizumab. Ophthalmology 2008; 115: 1268.
- Lopez-Guajardo L, del Valle FG, Moreno JP et al. Reduction of pegaptanib loss during intravitreal delivery using an oblique injection technique. Eye. 2008;22(3):430–3.
- Rodrigues EB, Meyer CH, Grumann et al. Tunelled scleral incision to prevent vitreous reflux after intravitreal injection. Am J Ophthalmol 2007; 143(6):1035–1037.
- Benz MS, Albini TA, Holz ER et al. Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide. Ophthalmology 2006; 113: 1174–1178.
- Bakri SJ, Pulido JS, McCannel CA, Hodge DO, Diehl N, Hillemeier J.Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab. Eye 2009; 23(1):181–5.